- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/10 | 1.59 | -31.26 | -2.87 | 19.55 | 11.0 | 5.76 | N/A | - | ||
2024/9 | 2.31 | 24.36 | 12.27 | 17.96 | 12.42 | 6.48 | 1.17 | - | ||
2024/8 | 1.86 | -19.34 | 11.1 | 15.65 | 12.44 | 6.15 | 1.23 | - | ||
2024/7 | 2.31 | 16.26 | 54.83 | 13.79 | 12.63 | 6.31 | 1.2 | 主要為特用化學品及植物保護用藥去年同月的營收基期相對較低,因而本月營業收入淨額相較成長54.83%。 | ||
2024/6 | 1.98 | -1.83 | 59.48 | 11.48 | 6.78 | 6.08 | 1.32 | 主要為特用化學品及植物保護用藥去年同月的營收基期相對較低,因而本月營業收入淨額相較成長59.48%。 | ||
2024/5 | 2.02 | -2.52 | -2.79 | 9.5 | -0.1 | 5.91 | 1.35 | - | ||
2024/4 | 2.07 | 14.33 | 23.88 | 7.48 | 0.64 | 5.53 | 1.45 | - | ||
2024/3 | 1.81 | 10.04 | -19.75 | 5.4 | -6.11 | 5.4 | 1.49 | - | ||
2024/2 | 1.65 | -15.12 | -9.91 | 3.59 | 2.7 | 5.24 | 1.53 | - | ||
2024/1 | 1.94 | 17.76 | 16.57 | 1.94 | 16.57 | 6.18 | 1.3 | - | ||
2023/12 | 1.65 | -36.43 | -36.92 | 21.86 | -27.35 | 5.88 | 1.5 | - | ||
2023/11 | 2.59 | 58.37 | 5.32 | 20.21 | -26.44 | 6.29 | 1.4 | - | ||
2023/10 | 1.64 | -20.54 | -16.92 | 17.61 | -29.56 | 5.37 | 1.64 | - | ||
2023/9 | 2.06 | 23.07 | 5.06 | 15.98 | -30.64 | 5.23 | 1.76 | - | ||
2023/8 | 1.67 | 12.4 | -25.78 | 13.92 | -33.97 | 4.41 | 2.08 | - | ||
2023/7 | 1.49 | 19.75 | -35.27 | 12.24 | -34.95 | 4.81 | 1.91 | - | ||
2023/6 | 1.24 | -40.17 | -39.45 | 10.75 | -34.91 | 5.0 | 1.99 | - | ||
2023/5 | 2.08 | 24.23 | -36.53 | 9.51 | -34.26 | 6.01 | 1.65 | - | ||
2023/4 | 1.67 | -25.94 | -48.0 | 7.43 | -33.6 | 5.76 | 1.73 | - | ||
2023/3 | 2.26 | 23.53 | -34.05 | 5.75 | -27.78 | 5.75 | 1.72 | - | ||
2023/2 | 1.83 | 9.83 | 3.94 | 3.49 | -23.04 | 6.11 | 1.62 | - | ||
2023/1 | 1.67 | -36.28 | -40.12 | 1.67 | -40.12 | 6.74 | 1.47 | - | ||
2022/12 | 2.61 | 6.15 | 0.01 | 30.09 | 5.53 | 7.05 | 1.51 | - | ||
2022/11 | 2.46 | 24.92 | -19.59 | 27.47 | 6.09 | 6.4 | 1.66 | - | ||
2022/10 | 1.97 | 0.48 | -26.92 | 25.01 | 9.54 | 6.19 | 1.72 | - | ||
2022/9 | 1.96 | -13.06 | -12.99 | 23.04 | 14.42 | 6.52 | 1.61 | - | ||
2022/8 | 2.26 | -1.96 | 16.16 | 21.08 | 17.88 | 6.61 | 1.59 | - | ||
2022/7 | 2.3 | 12.02 | 27.54 | 18.82 | 18.09 | 7.63 | 1.38 | - | ||
2022/6 | 2.05 | -37.29 | -15.6 | 16.52 | 16.89 | 8.55 | 1.05 | - | ||
2022/5 | 3.28 | 1.78 | 42.14 | 14.46 | 23.65 | 9.92 | 0.91 | - | ||
2022/4 | 3.22 | -6.07 | 51.45 | 11.19 | 19.11 | 8.41 | 1.07 | 主要為特用化學品中除受匯率影響外,抗氧化劑及阻燃劑訂價調整或出貨增加,故本月營業收入淨額較去年同期增加51.45%。 | ||
2022/3 | 3.43 | 94.73 | 23.03 | 7.97 | 9.65 | 7.97 | 1.12 | - | ||
2022/2 | 1.76 | -36.73 | -2.38 | 4.54 | 1.34 | 7.16 | 1.24 | - | ||
2022/1 | 2.78 | 6.42 | 3.85 | 2.78 | 3.85 | 8.46 | 1.05 | - | ||
2021/12 | 2.61 | -14.65 | 29.6 | 28.51 | 3.56 | 8.37 | 0.97 | - | ||
2021/11 | 3.06 | 13.54 | 29.26 | 25.89 | 1.5 | 8.01 | 1.01 | - | ||
2021/10 | 2.7 | 19.62 | 39.28 | 22.83 | -1.34 | 6.89 | 1.18 | - | ||
2021/9 | 2.25 | 16.07 | 12.01 | 20.13 | -5.05 | 6.0 | 1.18 | - | ||
2021/8 | 1.94 | 7.63 | -2.69 | 17.88 | -6.84 | 6.18 | 1.15 | - | ||
2021/7 | 1.8 | -25.87 | -18.11 | 15.94 | -7.32 | 6.54 | 1.08 | - | ||
2021/6 | 2.43 | 5.62 | 10.98 | 14.13 | -5.73 | 6.86 | 0.88 | - | ||
2021/5 | 2.3 | 8.44 | 8.8 | 11.7 | -8.6 | 7.22 | 0.83 | - | ||
2021/4 | 2.13 | -23.69 | -10.56 | 9.39 | -12.05 | 6.71 | 0.9 | - | ||
2021/3 | 2.79 | 54.49 | -3.06 | 7.27 | -12.47 | 7.27 | 0.83 | - | ||
2021/2 | 1.8 | -32.69 | -38.12 | 4.48 | -17.46 | 6.5 | 0.93 | - | ||
2021/1 | 2.68 | 32.82 | 6.47 | 2.68 | 6.47 | 7.06 | 0.86 | - | ||
2020/12 | 2.02 | -14.88 | -22.91 | 27.53 | -15.14 | 6.32 | 1.12 | - | ||
2020/11 | 2.37 | 22.34 | -4.77 | 25.51 | -14.46 | 6.32 | 1.12 | - | ||
2020/10 | 1.94 | -3.79 | -33.38 | 23.14 | -15.34 | 5.95 | 1.19 | - | ||
2020/9 | 2.01 | 0.83 | -25.39 | 21.2 | -13.2 | 6.21 | 1.21 | - | ||
2020/8 | 2.0 | -9.42 | -27.08 | 19.19 | -11.68 | 6.39 | 1.18 | - | ||
2020/7 | 2.2 | 0.47 | -19.12 | 17.19 | -9.46 | 6.52 | 1.16 | - | ||
2020/6 | 2.19 | 3.54 | -0.49 | 14.99 | -7.85 | 6.69 | 1.09 | - | ||
2020/5 | 2.12 | -10.85 | -24.27 | 12.8 | -9.0 | 7.37 | 0.99 | - | ||
2020/4 | 2.38 | -17.29 | -10.63 | 10.68 | -5.21 | 8.16 | 0.9 | - | ||
2020/3 | 2.87 | -1.38 | -1.73 | 8.3 | -3.53 | 8.3 | 0.87 | - | ||
2020/2 | 2.91 | 15.82 | 36.66 | 5.43 | -4.46 | 8.05 | 0.9 | - | ||
2020/1 | 2.52 | -3.83 | -29.15 | 2.52 | -29.15 | 7.62 | 0.95 | - | ||
2019/12 | 2.62 | 5.14 | -4.51 | 32.44 | -6.01 | 0.0 | N/A | - | ||
2019/11 | 2.49 | -14.41 | -2.09 | 29.82 | -6.14 | 0.0 | N/A | - |
年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
---|---|---|---|---|---|---|---|---|---|
2024/1 | 1.94 | 2023/1 | 1.67 | 2022/1 | 2.78 | 2021/1 | 2.68 | 2020/1 | 2.52 |
2024/2 | 1.65 | 2023/2 | 1.83 | 2022/2 | 1.76 | 2021/2 | 1.8 | 2020/2 | 2.91 |
2024/3 | 1.81 | 2023/3 | 2.26 | 2022/3 | 3.43 | 2021/3 | 2.79 | 2020/3 | 2.87 |
2024/4 | 2.07 | 2023/4 | 1.67 | 2022/4 | 3.22 | 2021/4 | 2.13 | 2020/4 | 2.38 |
2024/5 | 2.02 | 2023/5 | 2.08 | 2022/5 | 3.28 | 2021/5 | 2.3 | 2020/5 | 2.12 |
2024/6 | 1.98 | 2023/6 | 1.24 | 2022/6 | 2.05 | 2021/6 | 2.43 | 2020/6 | 2.19 |
2024/7 | 2.31 | 2023/7 | 1.49 | 2022/7 | 2.3 | 2021/7 | 1.8 | 2020/7 | 2.2 |
2024/8 | 1.86 | 2023/8 | 1.67 | 2022/8 | 2.26 | 2021/8 | 1.94 | 2020/8 | 2.0 |
2024/9 | 2.31 | 2023/9 | 2.06 | 2022/9 | 1.96 | 2021/9 | 2.25 | 2020/9 | 2.01 |
2024/10 | 1.59 | 2023/10 | 1.64 | 2022/10 | 1.97 | 2021/10 | 2.7 | 2020/10 | 1.94 |
N/A | N/A | 2023/11 | 2.59 | 2022/11 | 2.46 | 2021/11 | 3.06 | 2020/11 | 2.37 |
N/A | N/A | 2023/12 | 1.65 | 2022/12 | 2.61 | 2021/12 | 2.61 | 2020/12 | 2.02 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
合約負債 QoQ YoY | |||
---|---|---|---|
24Q3 (20) | 0.03 | -57.14 | -95.59 |
24Q2 (19) | 0.07 | 40.0 | -92.22 |
24Q1 (18) | 0.05 | -80.0 | -95.1 |
23Q4 (17) | 0.25 | -63.24 | -69.14 |
23Q3 (16) | 0.68 | -24.44 | 7.94 |
23Q2 (15) | 0.9 | -11.76 | 800.0 |
23Q1 (14) | 1.02 | 25.93 | 5000.0 |
22Q4 (13) | 0.81 | 28.57 | 1925.0 |
22Q3 (12) | 0.63 | 530.0 | 1160.0 |
22Q2 (11) | 0.1 | 400.0 | 400.0 |
22Q1 (10) | 0.02 | -50.0 | -90.91 |
21Q4 (9) | 0.04 | -20.0 | -78.95 |
21Q3 (8) | 0.05 | 150.0 | -73.68 |
21Q2 (7) | 0.02 | -90.91 | -90.48 |
21Q1 (6) | 0.22 | 15.79 | 15.79 |
20Q4 (5) | 0.19 | 0.0 | -5.0 |
20Q3 (4) | 0.19 | -9.52 | 0.0 |
20Q2 (3) | 0.21 | 10.53 | 0.0 |
20Q1 (2) | 0.19 | -5.0 | 0.0 |
19Q4 (1) | 0.2 | 0.0 | 0.0 |